Precirix
Series BBrussels, BelgiumMar 2022
Precirix raised €80M in a Series B round in Mar 2022. The company is based in Brussels, Belgium. Investors in the round: BioMedPartners, Forbion, GIMV and 6 others. Data as of Nov 2026.
Amount raised
€80M
€80,000,000
Native amount
80,000,000 EUR
Stage
Series B
series b
Investors
9
Provenance & confidence
Low confidenceAmount
Reported in EUR — no conversion. €80M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
9 namedBioMedPartnersForbionGIMVHealthCapINKEF CapitalJeito CapitalNovo HoldingsPontifax FundsV-Bio Ventures
Date
Mar 2022
Round type
series b
Amount (EUR)
€80M
Other rounds
same companyThis is the company's only recorded round.